To evaluate the safety and clinical efficacy of laparoscopic hepatectomy in the treatment of hepatic hemangioma.

Clinical data of 58 patients with hepatic hemangioma who underwent laparoscopic hepatectomy in Hai'an People's Hospital Affiliated to Nantong University from January 2010 to January 2018 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among 58 patients, 22 cases were male and 36 female, aged from 33 to 68 years with a median age of 48 years. 5 patients were diagnosed with multiple hepatic hemangiomas and 53 cases with single hepatic hemangioma. The diameter of hemangioma was 6-19 cm, and located at liver segments Ⅱ-Ⅵ. Laparoscopic non-anatomical or anatomical hepatectomy were performed in the patients. The intraoperative status and prognosis were analyzed.

One case was converted to open surgery, and the remaining 57 cases underwent laparoscopic hepatectomy successfully. Anatomical hepatectomy was performed in 24 cases including 15 cases left lateral lobectomy, 3 left hemihepatectomy, 2 right hemihepatectomy and 4 segmental hepatectomy. Non-anatomical hepatectomy was performed in 33 cases. The median operation time was 176 (107-244) min and the intraoperative blood loss was 372 (190-553) ml. No perioperative death, postoperative complication, such as massive intra-abdominal hemorrhage, bile leakage and liver failure, was observed. The average postoperative length of hospital stay was (7.1±2.3) d. Hepatic cavernous hemangioma was confirmed by postoperative pathological examination. No hemangioma recurrence was observed during the follow-up.

Laparoscopic hepatectomy is a safe, feasible and efficacious treatment for hepatic hemangioma, which possesses the advantages of rapid recovery and small incision, etc.